Dr. Shelly S. Lo, MD

Dr. Lo practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Lo's NPI, 1013994086, was assigned on December 29, 2005. Dr. Lo graduated from SUNY Upstate Medical University in 1997. Dr. Lo holds Illinois license 36111532.

Dr. Lo's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Lo's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Lo is also affiliated with Loyola University Medical Center. The medical group on file is Rush University Internists.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lo practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lo's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lo is board certified in hospice and palliative medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lo's licenses on file in 2 states: Illinois and Pennsylvania.

Dmand AI lists breast cancer, colorectal cancer, deep vein thrombosis (DVT), lung cancer, lymphoma and prostate cancer among the conditions Dr. Lo treats.

CMS data shows 712 Medicare services from Dr. Lo across 4 procedure codes in 2024, for 220 Medicare patients. Medicare paid $38,603 for them.

CMS counts 220 Medicare patients who saw Dr. Lo in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have cancer, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lo's median patient age at 69, with 98% women.

In 2024, Dr. Lo wrote 827 Medicare Part D claims for 225 patients. 80% of them were for generic drugs. CMS names the drug for 684 of them, across 10 drugs with 11 or more claims each, at $1,206,955 in total drug cost. In 2023, CMS named 452 claims across 6 drugs.

Dr. Lo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lo as offering telehealth.

Dmand AI links 22 papers to Dr. Lo, published from 2010 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Biomarkers, Tumor. Dr. Lo has published most often in JAMA Oncol. Dr. Lo's most frequent co-authors are Kathy Sue Albain, MD, Dawn Lauryn Hershman, MD and Katherine D. Crew, MD, MS.

Dmand AI links Dr. Lo to 8 clinical trials, 4 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Neoplasms, Male and Carcinoma, Intraductal, Noninfiltrating.

CMS Open Payments shows 5 general payments to Dr. Lo from 3 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 96% of the total. Merck Sharp & Dohme Corporation paid the most, $192.

Dmand AI lists 1 award for Dr. Lo, most recently CMS Stage 1 EHR in 2013.

Dr. Lo graduated from SUNY Upstate Medical University in 1997.

Dr. Lo is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.